Predictive Oncology Stock Investor Sentiment

POAI Stock  USD 1.27  0.02  1.55%   
Under 61% of Predictive Oncology's investor base is looking to short. The analysis of overall sentiment of trading Predictive Oncology stock suggests that many investors are alarmed at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
  
over six months ago at investorplace.com         
Why Is Predictive Oncology Stock Up 70 percent Today?
sbwire news
over six months ago at finance.yahoo.com         
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer ...
Yahoo News
over six months ago at www.macroaxis.com         
Disposition of tradable shares by Bush Pamela of Predictive Oncology subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Predictive Oncology Shares Pass Below 200 Day Moving Average of 2.29 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Predictive Oncology Share Price Passes Below 200-Day Moving Average of 2.42 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Predictive Oncology Stock Price Crosses Below 200 Day Moving Average of 2.52 - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and ...
Yahoo News
over six months ago at investing.com         
Predictive Oncology files IP for new GPCR technology
Investing News at Macroaxis
over six months ago at benzinga.com         
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and ...
benzinga news
over six months ago at globenewswire.com         
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and ...
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Predictive Oncology Share Price Passes Below 200-Day Moving Average of 2.59 - Defense World
Google News at Macroaxis
over six months ago at globenewswire.com         
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discover...
Macroaxis News: globenewswire.com
over six months ago at investing.com         
Predictive Oncology launches advanced 3D cell culture model
Investing News at Macroaxis
over six months ago at benzinga.com         
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
benzinga news
over six months ago at seekingalpha.com         
Predictive Oncology gains, to present positive results from a retrospective study
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Predictive Oncology that are available to investors today. That information is available publicly through Predictive media outlets and privately through word of mouth or via Predictive internal channels. However, regardless of the origin, that massive amount of Predictive data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Predictive Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Predictive Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Predictive Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Predictive Oncology alpha.

Predictive Oncology Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb 050100150
JavaScript chart by amCharts 3.21.15Predictive Oncology Predictive Oncology Dividend Benchmark Dow Jones Industrial
       Timeline  

Complementary Tools for Predictive Stock analysis

When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
News Freq…Investor S…